| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/22/2004 | CA2820949A1 Novel immunogenic proteins of leptospira |
| 04/22/2004 | CA2502281A1 Use of monoclonal antibodies to distinguish protein conformational isoforms |
| 04/22/2004 | CA2501945A1 Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof |
| 04/22/2004 | CA2501941A1 Secreted acid phosphatase (sapm) is present only in pathogenic mycobacteria and expressed selectively at acidic ph |
| 04/22/2004 | CA2501939A1 Novel immunogenic proteins of leptospira |
| 04/22/2004 | CA2501752A1 Compositions, organisms and methodologies employing a novel human kinase |
| 04/22/2004 | CA2501626A1 Methods for treating post-surgical pain by administering a nerve growth factor antagonist and compositions containing the same |
| 04/22/2004 | CA2501616A1 Antibody therapy |
| 04/22/2004 | CA2501581A1 Recombinant catalytic polypeptides and their uses |
| 04/22/2004 | CA2501235A1 Methods for treating cancer by inhibiting wnt signaling |
| 04/22/2004 | CA2500901A1 Methods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonists |
| 04/22/2004 | CA2500739A1 Diagnosis and monitoring of inflammation, ischemia and appendicitis |
| 04/22/2004 | CA2500665A1 Methods of regulating body weight |
| 04/22/2004 | CA2499081A1 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
| 04/22/2004 | CA2497798A1 Production of peptides in plants as viral coat protein fusions |
| 04/22/2004 | CA2494104A1 Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders |
| 04/21/2004 | EP1411357A1 Cancer diagnostics |
| 04/21/2004 | EP1411124A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/21/2004 | EP1411118A1 CELL PROLIFERATION INHIBITORS CONTAINING ANTI−GLYPICAN 3 ANTIBODY |
| 04/21/2004 | EP1411064A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| 04/21/2004 | EP1411063A1 Peptide nucleic acids |
| 04/21/2004 | EP1410807A1 Methods and compositions useful for inhibition of angiogenesis |
| 04/21/2004 | EP1410806A1 Remedies for mammary cancer |
| 04/21/2004 | EP1410036A2 Methods and compositions for diagnosing and treating a subject having depression |
| 04/21/2004 | EP1410035A2 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 04/21/2004 | EP1410022A2 Detection and treatment of prostate cancer |
| 04/21/2004 | EP1409727A2 Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells |
| 04/21/2004 | EP1409715A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 04/21/2004 | EP1409713A1 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 04/21/2004 | EP1409710A1 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 04/21/2004 | EP1409692A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine |
| 04/21/2004 | EP1409684A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 04/21/2004 | EP1409683A2 i HELICOBACTER /i PROTEINS, NUCLEIC ACIDS AND USES THEREOF |
| 04/21/2004 | EP1409682A2 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
| 04/21/2004 | EP1409681A2 Proteins and nucleic acids encoding same |
| 04/21/2004 | EP1409680A2 Novel human proton-gated channels |
| 04/21/2004 | EP1409677A2 Receptors and membrane-associated proteins |
| 04/21/2004 | EP1409676A2 Cd109 nucleic acid molecules polypeptides and methods of use |
| 04/21/2004 | EP1409675A1 Gene involved in apoptosis regulation |
| 04/21/2004 | EP1409673A2 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
| 04/21/2004 | EP1409661A2 Hdac9 polypeptides and polynucleotides and uses thereof |
| 04/21/2004 | EP1409660A2 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof |
| 04/21/2004 | EP1409658A2 Aggrecanase molecules |
| 04/21/2004 | EP1409655A2 Immunoglobulin superfamily proteins |
| 04/21/2004 | EP1409654A1 Immunological control of beta-amyloid levels in vivo |
| 04/21/2004 | EP1409550A1 Extracellular messengers |
| 04/21/2004 | EP1409549A2 Compositions and methods for the diagnosis and treatment of tumor |
| 04/21/2004 | EP1409547A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 04/21/2004 | EP1409546A2 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 04/21/2004 | EP1409544A2 Human dr4 antibodies and uses thereof |
| 04/21/2004 | EP1409542A2 Blood group antigen fusion polypeptides and methods of use thereof |
| 04/21/2004 | EP1409538A1 Process for obtaining growth factor (tgf-beta and igf-1), lactoperoxidase and immunoglobulins preparations from milk products having low mutual cross-contamination |
| 04/21/2004 | EP1409537A2 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques |
| 04/21/2004 | EP1409535A2 Human secreted proteins |
| 04/21/2004 | EP1409531A2 Heterocarpine, a human ghrh-binding protein |
| 04/21/2004 | EP1409523A2 Pancam nucleic acids and polypeptides |
| 04/21/2004 | EP1409518A1 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis |
| 04/21/2004 | EP1409018A2 Stable lyophilized pharmaceutical formulation of igg antibodies |
| 04/21/2004 | EP1409016A2 Antibodies to opgl |
| 04/21/2004 | EP1409015A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 04/21/2004 | EP1408996A2 A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| 04/21/2004 | EP1408908A2 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 04/21/2004 | EP1408811A2 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 04/21/2004 | EP1408808A2 Methods for diagnosing and treating heart disease |
| 04/21/2004 | EP1408753A2 Compounds effecting neuron remodeling and assays for same |
| 04/21/2004 | EP1287355B1 Methods and compounds for influencing beta3 integrin-dependent intracellular processes |
| 04/21/2004 | EP1232396B1 Assay of isomerised and/or optically inverted proteins |
| 04/21/2004 | EP1116031A4 DIAGNOSTIC ASSAYS FOR DETECTION OF $i(ENTAMOEBA HISTOLYTICA) |
| 04/21/2004 | EP0836647B1 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/21/2004 | CN1491281A Neurotonin and use thereof |
| 04/21/2004 | CN1491232A Modified leptin with reduced immunogenicity |
| 04/21/2004 | CN1491231A Modified keratinocyte growth factor (KGF) with reduced immunogenicity |
| 04/21/2004 | CN1490408A Antihuman seminal specific protein P30 detection reagent strips and monoclone antibody therewith |
| 04/21/2004 | CN1490407A Antihuman hemoglobin detection reagent strips and monoclone antibody contained therewith |
| 04/21/2004 | CN1490334A Affinity purifying method for gene specific antibody |
| 04/21/2004 | CN1146445C Materials and methods relating to diagnosis and treatment of pre-eclampsia and diabetes |
| 04/21/2004 | CN1146442C Lympha toxin-alpha/beta compositions as anti tumor agent and antilympha toxin beta receptor antibody |
| 04/21/2004 | CN1146441C Composition of containing lympha toxin beta receptor |
| 04/21/2004 | CN1146440C Vascular endothelial growth factor-B |
| 04/20/2004 | US6723833 Improved polypeptides, including antibodies, which not only don't exhibit the ?deactivating? event of aspartyl isomerization, but also display equal to or better than affinity to the target molecule (e.g., antigen) |
| 04/20/2004 | US6723832 Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof |
| 04/20/2004 | US6723831 Removal antibodies from body fluids |
| 04/20/2004 | US6723830 Short peptides which selectively modulate the activity of protein kinases |
| 04/20/2004 | US6723705 Gene expression; activating t-cells ability to bind cd28 or ctla4 ligands; antimetastasis and anticarcinogenic agents |
| 04/20/2004 | US6723698 Methods and compositions for the treatment of motor neuron injury and neuropathy |
| 04/20/2004 | US6723695 Cytotoxic epstein-barr virus (ebv) t-cell epitopes derived from ebv structural antigens; vaccines |
| 04/20/2004 | US6723570 Detecting expression of mammalian chemokine receptor; obtain cell sample, detect antibody binding, bound antibody indicates presence of receptor |
| 04/20/2004 | US6723556 Nucleic acid encoding a fragment of bovine luteinizing hormone/chorionic gonadotropin receptor |
| 04/20/2004 | US6723552 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 04/20/2004 | US6723538 Therapy for infections, immunology diseases |
| 04/20/2004 | US6723535 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 04/20/2004 | US6723519 Compositions and method for determining the presence of rat PTTG peptide in a sample |
| 04/20/2004 | US6723518 Diagnosing mammary gland pathologies; obtain biopsies, screen for expression of chemokines, presence of chemokine indicates pathology |
| 04/20/2004 | US6723320 Using monoclonal antibodies; polymerase chain reactions |
| 04/20/2004 | US6723319 Method of treating inflammatory intestinal diseases containing as the ingredient IL-6 receptors antibodies |
| 04/20/2004 | US6723317 Binds to amino acid sequence 1,2 or 4; identification of human papillomavirus (hpv) 16 viral structures |
| 04/20/2004 | CA2248182C Porcine reproductive and respiratory syndrome vaccine |
| 04/20/2004 | CA1341454C Alpha-amidating enzyme compositions and processes for their production and use |
| 04/16/2004 | CA2408207A1 Peptides binding protein phosphatase 2a and polynucleotides coding them |
| 04/15/2004 | WO2004031400A2 Amyloid beta-derived diffusible ligands (addls), addl-surrogates, addl-binding molecules, and uses thereof |